By Aaron Derfel, Gazette Health Reporter Critics doubt benefits for women up to age 45. MONTREAL – Health Canada’s decision to approve the Gardasil vaccine for women up to the age of 45 has renewed the debate about the purported benefits of the shots and whether they might even be necessary. Kirkland-based Merck, maker of […]
Merck, Qiagen Begin Rwandan Cervical-Cancer Program, Times Says
By Heather Murdock Merck & Co. and Qiagen NV (QGEN) will fund a program in Rwanda to screen and vaccinate women against cervical cancer, the New Times reported, citing Agnes Binagwaho, permanent secretary in the Health Ministry. Merck will provide more than 2 million doses of its Gardasil vaccine to the government at no charge, […]
Rwanda: Over 100,000 Schoolgirls to Get Cervical Cancer Vaccine
By Edwin Musoni About 100,000 girls in primary schools will benefit from a new vaccine against Human Papilloma Virus (HPV) which causes cervical cancer. This was revealed by the head of adolescent and reproductive health in the Ministry of Health, Dr. Diane Mutamba, in an interview with The New Times. “The official launch of the […]
The Emergence of Vaccine Induced Diseases
Merck, the manufacturer of Gardasil, a vaccine they claim prevents cervical cancer, seems more to be about sterilizing young girls, if the vaccine doesn’t kill or permanently injure them first. Every attempt has been made by state and federal governments to make this deadly vaccine mandatory. Thousands of young girls are subjected to the Gardasil […]
Alternative Gardasil dosing schedules effective
By Nicole Blazek Patients that were administered the three-dose quadrivalent human papillomavirus vaccine (Gardasil, Merck) with longer intervals between each dose had similar immune responses to those administered the vaccine on a standard dosing schedule, new data indicate. “Clinicians can be reassured that if delays occur in administering the second and third doses of this […]
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 80
- Next Page »
